Abstract:
The objective of this study was to investigate the impact and underly mechanism of insulin-like growth factor 2 mRNA binding protein 1(IGF2BP1) on the in vitro functions of esophageal squamous cells(ESCC). We employed the TIMER2.0 database, immunohistochemistry, and real-time quantitative PCR(RT-qPCR) to examine the protein and mRNA levels of IGF2BP1 in esophageal cancer tissues and adjacent tissues. The expression of IGF2BP1 in KYSE30 and TE-1 cells was suppressed using siRNA, the impact of IGF2BP1 knockdown on cell function was assessed through CCK-8 assay, colony formation assay, scratch wound hea-ling assay, Trans-well assay, and flow cytometry. Western blot analysis was conducted to evaluate the influence of IGF2BP1 knockdown on epithelial-mesenchymal transition(EMT)-related proteins and phosphorylation levels of the PI3K/AKT pathway. The remaining N~6-methyladenosine(m~6A) methylases interacting with IGF2BPl proteins were selected using the STRING, GEPIA databases and used for differential expression analysis.The downstream target genes and their m~6A modification sites were predicted by the RM2Target and SRAMP databases.The findings revealed that IGF2BP1 was highly expressed in both ESCC tissues and cells(P<0.05 or P<0.001). After knocking down IGF2BP1, the proliferation, migration, and invasion capacities of KYSE30 and TE-1 cells were significantly attenuated(P<0.05 or P<0.001), while cellular apoptosis was markedly increased(P<0.05 or P<0.001). Concurrently, it facilitated the upregulation of E-cadherin expression(P<0.05 or P<0.01) and suppressed the expression of N-cadherin and Vimentin(P<0.05 or P<0.01), as well as phosphorylation of the PI3K/AKT signaling pathway(P<0.05 or P<0.01).Zinc finger CCCH domain containing protein 13(ZC3H13) interacted with the IGF2BP1 protein, and its expression level exhibited a positive correlation with that of IGF2BP1 in ESCC.The potential target genes CNNM2, KIAA1549, and SP3, which were co-regulated by ZC3H13 and IGF2BP1, all possessed highly credible m~6A modification sites. This study suggested that IGF2BP1 may interacted with other m~6A methyltransferases in an m~6A-dependent manner to activate the phosphorylation of the PI3K/AKT pathway, thereby facilitated proliferation, migration, and invasion of ESCC cells. Additionally, it suppressed apoptosis and promoted EMT, thus exerted carcinogenic effects.